Visionflex Group Limited (ASX:VFX, ABN 25 138 897 533) is a clinical virtual care technology company that provides healthcare, telehealth, and remote diagnostic solutions to local and international markets. The company's product suite includes the ProEX clinical virtual care software platform, the Vision Telehealth …
Cochlear Limited (ASX:COH) is the global leader in implantable hearing devices,Manufacturingcochlear implants, bone-anchored hearing implants and acoustic implants. Cochlear implants serve people with severe-to-profound hearing loss by bypassing damaged hair cells in the cochlea and directly stimulating the auditory nerve. The company operates across …
4DMedical Limited (ASX:4DX) released its FY26 full year results on 28 August 2026 for the year ended 30 June 2026.Operating Revenuewas $7.1 million, up 21%, with gross margins above 90%. Underlying SaaS revenue rose 23%, the company delivered software at 540 sites globally (up …
Medibank Private Limited is Australia's largest private health insurer by policyholders, trusted by approximately 6 million people. The company operates twoHealth Insurancebrands — Medibank and ahm — and has a growing health services division through Amplar Health, which delivers GP consults, community nursing, allied …
Ramsay Health Care Limited is one of the world's largest private hospital operators, with hospitals and healthcare facilities across Australia, the United Kingdom, France, Sweden, Norway, Italy, and Indonesia. In Australia, Ramsay operates more than 70 hospitals and day surgeries, making it Australia's largest …
Mayne Pharma and Orthocell are both small-cap healthcare companies trading well below their highs. Their next moves are likely to depend on very different things. For Mayne, the question is what the board does next after itsTakeovercollapsed, and how the Cosette litigation ends. For …
Telix Pharmaceuticals (ASX:TLX) has reached an important regulatory milestone after securing United States Food and Drug Administration approval for Pixclara, its brain-cancer imaging agent.
Perth-based PYC Therapeutics continues to advance its pipeline of RNA therapies built on a proprietary cell-penetrating peptide delivery platform. The company's most advanced work targets inherited retinal disease, including retinitis pigmentosa, with additional programmes spanning autosomal dominant optic atrophy, autosomal dominant polycystic kidney disease …
On 26 August 2026, PolyNovo released its FY26 full-year results, following a preliminary trading update on 23 July 2026 that had already flagged record revenue. The company highlighted record sales recorded in the US in June, underscoring the ongoing commercial ramp of its NovoSorb …
Trajan produces analytical and life-science products, including gas purifiers and filters, inlet liners, syringes and sampling equipment, with operations spanning Malaysia, Japan, Australia and other regions. In its most recent full-year results, released in late August 2026, the company highlightedMarginand EBITDA improvements in the …